Cannabinoid · Metabolite
7-Hydroxy-cannabidiol (7-OH-CBD) is a cannabinoid metabolite formed in the body, in the CBD metabolite group. The major active metabolite the liver makes from CBD.
Where it fits
7-Hydroxy-cannabidiol (7-OH-CBD) derives from CBD (liver CYP). See the Synthetic & altered cannabinoids index for how it relates to the rest of the family.
What the research shows
7-Hydroxy-cannabidiol (7-OH-CBD) has preclinical-level evidence; see the class index and related compounds for cited studies.
Frequently Asked Questions
Is 7-hydroxy-CBD (7-OH-CBD) intoxicating?
No. 7-Hydroxy-cannabidiol (7-OH-CBD) is non-intoxicating and does not activate CB1 receptors in the way delta-9-THC or 11-hydroxy-THC does.
Which liver enzymes convert CBD into 7-OH-CBD?
Human pharmacokinetic and in-vitro microsomal studies show that cytochrome P450 2C19 (CYP2C19) is the primary enzyme responsible for 7-hydroxylation of CBD into 7-OH-CBD, with minor contribution from CYP2C9.
Is 7-OH-CBD pharmacologically active?
Yes. Unlike the downstream metabolite 7-COOH-CBD, 7-OH-CBD retains anticonvulsant activity in preclinical seizure models and contributes to the clinical pharmacology of oral cannabidiol.
Sources
- Beers, J. L., Fu, D., & Jackson, K. D. (2021). Cytochrome P450-catalyzed metabolism of cannabidiol to the active metabolite 7-hydroxy-cannabidiol. Drug Metabolism and Disposition, 49(10), 882-891. PubMed 34045238
- Jiang, R., Yamaori, S., Takeda, S.,山本, I., & Watanabe, K. (2011). Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes. Life Sciences, 89(5-6), 165-170. PubMed 21704641
- Ujváry, I., & Hanuš, L. (2016). Human metabolites of cannabidiol: a review on their formation, biological activity, and relevance in therapy. Cannabis and Cannabinoid Research, 1(1), 90-101. PubMed 28861484
- Taylor, L., Gidal, B., Blakey, G., Tayo, B., & Morrison, G. (2018). A Phase I, randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly purified cannabidiol in healthy subjects. CNS Drugs, 32(11), 1053-1067. PubMed 30374606
Part of the NOIDS cannabinoids index. Educational reference, not medical advice.